- info@anseaconsulting.com
- Singapore: +65 6956 6164
- Basel: +41 61 564 1420
Develop Singapore-specific HTA submission materials by localizing the Global Value Dossier and adapting the Budget Impact Model (BIM) and Cost-Effectiveness Analysis (CEA) models to meet Agency for Care Effectiveness (ACE) requirements for CAR-T therapy reimbursement evaluation.
Reviewed global evidence and Singapore ACE submission requirements, localized the value dossier using country-specific clinical and epidemiological data, conducted systematic literature reviews, incorporated local healthcare resource utilization & cost inputs, and adapted BIM and CEA models with supporting technical reports.
Comprehensive Singapore HTA submission package including localized Global Value Dossiers for DLBCL and FL indications, adapted Budget Impact and Cost-Effectiveness models, BIM and CEA technical reports, local evidence synthesis, and country-specific economic analyses ready for ACE submission.
Successfully delivered a complete Singapore-specific evidence package supporting HTA submission, providing robust clinical and economic evidence through localized dossiers and validated health economic models to facilitate reimbursement evaluation and market access decision-making.